WallStSmart

Aspen Aerogels Inc (ASPN)vsLinde plc Ordinary Shares (LIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Linde plc Ordinary Shares generates 17441% more annual revenue ($35.45B vs $202.09M). LIN leads profitability with a 20.4% profit margin vs -62.5%. LIN earns a higher WallStSmart Score of 64/100 (C+).

ASPN

Avoid

28

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 7.5
Piotroski: 4/9Altman Z: 44.42

LIN

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 3/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ASPN.

LINSignificantly Overvalued (-50.9%)

Margin of Safety

-50.9%

Fair Value

$308.97

Current Price

$466.22

$157.25 premium

UndervaluedFair: $308.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASPN2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
44.4210/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

LIN3 strengths · Avg: 9.0/10
Market CapQuality
$214.92B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
28.1%8/10

Strong operational efficiency at 28.1%

Areas to Watch

ASPN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$407.48M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-65.6%2/10

ROE of -65.6% — below average capital efficiency

Revenue GrowthGrowth
-36.1%2/10

Revenue declined 36.1%

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
1.794/10

Expensive relative to growth rate

P/E RatioValuation
29.8x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ASPN

The strongest argument for ASPN centers on Altman Z-Score, Price/Book.

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.1%.

Bear Case : ASPN

The primary concerns for ASPN are EPS Growth, Market Cap, Return on Equity.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

ASPN profiles as a turnaround stock while LIN is a mature play — different risk/reward profiles.

ASPN carries more volatility with a beta of 2.97 — expect wider price swings.

LIN is growing revenue faster at 9.3% — sustainability is the question.

LIN generates stronger free cash flow (833M), providing more financial flexibility.

Bottom Line

LIN scores higher overall (64/100 vs 28/100), backed by strong 20.4% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aspen Aerogels Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Aspen Aerogels, Inc. designs, develops, manufactures, and sells airgel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company is headquartered in Northborough, Massachusetts.

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

Want to dig deeper into these stocks?